Report Detail
Global Dermatology Drug Market Growth 2019-2024
- RnM2975533 |
- 18 February, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Dermatology Drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases.
The classification of Dermatology Drug includes External Use, Oral and Injection, and the revenue proportion of External Use in 2015 is about 73.74%.
Dermatology Drug is widely used for Psoriasis, Skin Infections, Acne, Dermatitis and other skin diseases. Amongst these different types of skin diseases, Psoriasis was the largest revenue generating segment in 2015, and the revenue market share is about 48.04%.
According to this study, over the next five years the Dermatology Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dermatology Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dermatology Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Dermatology Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
External Use
Oral
Injection
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Psoriasis
Skin Infections
Acne
Dermatitis
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dermatology Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Dermatology Drug market by identifying its various subsegments.
Focuses on the key global Dermatology Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dermatology Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dermatology Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Dermatology Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Dermatology Drug Consumption 2014-2024
- 2.1.2 Dermatology Drug Consumption CAGR by Region
- 2.2 Dermatology Drug Segment by Type
- 2.2.1 External Use
- 2.2.2 Oral
- 2.2.3 Injection
- 2.3 Dermatology Drug Consumption by Type
- 2.3.1 Global Dermatology Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Dermatology Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Dermatology Drug Sale Price by Type (2014-2019)
- 2.4 Dermatology Drug Segment by Application
- 2.4.1 Psoriasis
- 2.4.2 Skin Infections
- 2.4.3 Acne
- 2.4.4 Dermatitis
- 2.4.5 Other
- 2.5 Dermatology Drug Consumption by Application
- 2.5.1 Global Dermatology Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Dermatology Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Dermatology Drug Sale Price by Application (2014-2019)
3 Global Dermatology Drug by Players
- 3.1 Global Dermatology Drug Sales Market Share by Players
- 3.1.1 Global Dermatology Drug Sales by Players (2017-2019)
- 3.1.2 Global Dermatology Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Dermatology Drug Revenue Market Share by Players
- 3.2.1 Global Dermatology Drug Revenue by Players (2017-2019)
- 3.2.2 Global Dermatology Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Dermatology Drug Sale Price by Players
- 3.4 Global Dermatology Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Dermatology Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Dermatology Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Dermatology Drug by Regions
- 4.1 Dermatology Drug by Regions
- 4.1.1 Global Dermatology Drug Consumption by Regions
- 4.1.2 Global Dermatology Drug Value by Regions
- 4.2 Americas Dermatology Drug Consumption Growth
- 4.3 APAC Dermatology Drug Consumption Growth
- 4.4 Europe Dermatology Drug Consumption Growth
- 4.5 Middle East & Africa Dermatology Drug Consumption Growth
5 Americas
- 5.1 Americas Dermatology Drug Consumption by Countries
- 5.1.1 Americas Dermatology Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Dermatology Drug Value by Countries (2014-2019)
- 5.2 Americas Dermatology Drug Consumption by Type
- 5.3 Americas Dermatology Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Dermatology Drug Consumption by Countries
- 6.1.1 APAC Dermatology Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Dermatology Drug Value by Countries (2014-2019)
- 6.2 APAC Dermatology Drug Consumption by Type
- 6.3 APAC Dermatology Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Dermatology Drug by Countries
- 7.1.1 Europe Dermatology Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Dermatology Drug Value by Countries (2014-2019)
- 7.2 Europe Dermatology Drug Consumption by Type
- 7.3 Europe Dermatology Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Dermatology Drug by Countries
- 8.1.1 Middle East & Africa Dermatology Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Dermatology Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Dermatology Drug Consumption by Type
- 8.3 Middle East & Africa Dermatology Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Dermatology Drug Distributors
- 10.3 Dermatology Drug Customer
11 Global Dermatology Drug Market Forecast
- 11.1 Global Dermatology Drug Consumption Forecast (2019-2024)
- 11.2 Global Dermatology Drug Forecast by Regions
- 11.2.1 Global Dermatology Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Dermatology Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Dermatology Drug Forecast by Type
- 11.8 Global Dermatology Drug Forecast by Application
12 Key Players Analysis
- 12.1 AbbVie
- 12.1.1 Company Details
- 12.1.2 Dermatology Drug Product Offered
- 12.1.3 AbbVie Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 AbbVie News
- 12.2 Johnson & Johnson
- 12.2.1 Company Details
- 12.2.2 Dermatology Drug Product Offered
- 12.2.3 Johnson & Johnson Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Johnson & Johnson News
- 12.3 Bayer
- 12.3.1 Company Details
- 12.3.2 Dermatology Drug Product Offered
- 12.3.3 Bayer Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Bayer News
- 12.4 Galderma
- 12.4.1 Company Details
- 12.4.2 Dermatology Drug Product Offered
- 12.4.3 Galderma Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Galderma News
- 12.5 Bristol-Myers Squibb
- 12.5.1 Company Details
- 12.5.2 Dermatology Drug Product Offered
- 12.5.3 Bristol-Myers Squibb Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Bristol-Myers Squibb News
- 12.6 Novartis
- 12.6.1 Company Details
- 12.6.2 Dermatology Drug Product Offered
- 12.6.3 Novartis Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Novartis News
- 12.7 Pfizer
- 12.7.1 Company Details
- 12.7.2 Dermatology Drug Product Offered
- 12.7.3 Pfizer Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer News
- 12.8 Merz Pharma
- 12.8.1 Company Details
- 12.8.2 Dermatology Drug Product Offered
- 12.8.3 Merz Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Merz Pharma News
- 12.9 Valeant
- 12.9.1 Company Details
- 12.9.2 Dermatology Drug Product Offered
- 12.9.3 Valeant Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Valeant News
- 12.10 LEO Pharma
- 12.10.1 Company Details
- 12.10.2 Dermatology Drug Product Offered
- 12.10.3 LEO Pharma Dermatology Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 LEO Pharma News
- 12.11 GlaxoSmithKline
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Dermatology Drug . Industry analysis & Market Report on Dermatology Drug is a syndicated market report, published as Global Dermatology Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Dermatology Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
